Cleared Traditional

K162037 - Eclipse with VEMP (FDA 510(k) Clearance)

Mar 2017
Decision
244d
Days
Class 2
Risk

K162037 is an FDA 510(k) clearance for the Eclipse with VEMP. This device is classified as a Stimulator, Auditory, Evoked Response (Class II - Special Controls, product code GWJ).

Submitted by Interacoustics A/S (Middelfart, DK). The FDA issued a Cleared decision on March 23, 2017, 244 days after receiving the submission on July 22, 2016.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1900.

Submission Details

510(k) Number K162037 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 22, 2016
Decision Date March 23, 2017
Days to Decision 244 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GWJ - Stimulator, Auditory, Evoked Response
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1900